Assess Sacubitril/Allisartan and Amlodipine in Patients With Essential Hypertension Uncontrolled With Sacubitril/Allisartan

NCT07704697 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

346

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Experimental: Sacubitril/Allisartan and Amlodipine Group
DRUG: Active Comparator: Sacubitril/Allisartan Group

Sponsor

Shenzhen Salubris Pharmaceuticals Co., Ltd.